Sort   by:  
 Page size 
UnknownModeling the dynamics of antibody-target binding in living tumors.
Not available
S-EPMC7542163 | biostudies-literature
UnknownChemotherapeutic dosing implicated by pharmacodynamic modeling of in vitro cytotoxic data: a case study of paclitaxel.
Not available
S-EPMC6505692 | biostudies-literature
UnknownSpatiotemporal Heterogeneity across Metastases and Organ-Specific Response Informs Drug Efficacy and Patient Survival in Colorectal Cancer.
Not available
S-EPMC8137573 | biostudies-literature
UnknownEmbracing Project Optimus: Can we Leverage Evolutionary Theory to Optimize Dosing in Oncology?
Not available
S-EPMC9789176 | biostudies-literature
UnknownA Minimal Physiologically Based Pharmacokinetic Model with a Nested Endosome Compartment for Novel Engineered Antibodies.
Not available
S-EPMC6486833 | biostudies-literature
UnknownA systems pharmacokinetic/pharmacodynamic model for concizumab to explore the potential of anti-TFPI recycling antibodies.
Not available
S-EPMC6824202 | biostudies-literature
UnknownModeling Tumor Evolutionary Dynamics to Predict Clinical Outcomes for Patients with Metastatic Colorectal Cancer: A Retrospective Analysis.
Not available
S-EPMC7002273 | biostudies-literature
UnknownDynamic metrics-based biomarkers to predict responders to anti-PD-1 immunotherapy.
Not available
S-EPMC6353899 | biostudies-literature
UnknownWhich factors matter the most? Revisiting and dissecting antibody therapeutic doses.
Not available
S-EPMC8410626 | biostudies-literature
UnknownMapping lesion-specific response and progression dynamics and inter-organ variability in metastatic colorectal cancer.
Not available
S-EPMC9876906 | biostudies-literature
Sort   by:  
 Page size